Looming revenue drop is changing the economics of pharmaceutical industry

Published: 2011-09-07 06:59:00

Updated: 2011-09-07 06:59:00

Multinational pharmaceutical firms will face a bumpy road in Korea as the patents on their blockbusters, which were filed years before the drugs went on sale, last for 20 years at most, and many expire soon.

The Fair Trade Commission (FTC) said Sunday that five global drug makers were found to...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK